WHO ICTRP trial
Evaluation of clinical efficacy and sustainability of COVID-19 booster…
JPRN-UMIN000048764 · Japan Primary Registries Network (JPRN) · Not Recruiting
Key facts
| Trial ID | JPRN-UMIN000048764 |
|---|---|
| Public title | Evaluation of clinical efficacy and sustainability of COVID-19 booster vaccination in patients with hematological diseases. |
| Scientific title | Evaluation of clinical efficacy and sustainability of COVID-19 booster vaccination in patients with hematological diseases. - Evaluation of clinical efficacy and sustainability of COVID-19 booster vaccination in patients with hematological diseases. |
| Primary sponsor | Blood Disorders Center, Aiiku Hospital |
| Registry | Japan Primary Registries Network (JPRN) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Phase | Not selected |
| Countries | Japan |
| Conditions | hematological diseases |
| Registration date | Aug 26, 2022 |
| Target size | 600 |
| Registry page | center6.umin.ac.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: